Acute lung injury complicating imported Plasmodium falciparum malaria

Chest. 1995 Sep;108(3):746-9. doi: 10.1378/chest.108.3.746.

Abstract

Study objective: To characterize adult patients with acute lung injury complicating severe imported Plasmodium falciparum malaria.

Design and setting: Retrospective study of patients with severe P falciparum malaria admitted to the medical ICU of a university hospital infectious diseases department.

Patients: Forty adults with complicated malaria, with (group 1, 12 patients) or without (group 2, 28 patients) acute lung injury.

Results: Patients with acute lung injury had a higher simplified acute physiology score on admission (24.2 +/- 3.2 vs 13.7 +/- 0.7 in group 2, p < 0.0001) and a longer time interval to adequate antimalarial therapy (8.8 +/- 2.5 vs 4.9 +/- 0.6 days in group 2, p = 0.046). Of the nine group 1 patients given mechanical ventilation, eight had a PaO2/FIO2 < or = 200 mm Hg. Two patients with moderate hypoxemia received oxygen through a nasal tube and one received continuous positive airway pressure via a face mask. Acute renal failure, unrousable coma, metabolic acidosis, and shock were significantly more common among group 1 patients. The number of complications of malaria was significantly higher in patients with acute lung injury (4.7 +/- 0.5 vs 1.6 +/- 0.1 in group 2, p < 0.0001). Five patients, including four with acute lung injury, had evidence of bacterial infection (pneumonia or primary bacteremia) at ICU admission. Four patients with acute lung injury died (33%) vs one patient without acute lung injury (4%, p = 0.022).

Conclusions: Acute lung injury is more likely to occur in patients with extremely severe, multisystemic P falciparum malaria. In patients with acute lung injury and septic shock, bacterial coinfection should be suspected and treated empirically since it contributes substantially to early mortality.

Publication types

  • Comparative Study

MeSH terms

  • Acidosis / etiology
  • Acute Kidney Injury / etiology
  • Adult
  • Africa
  • Bacterial Infections / complications
  • Case-Control Studies
  • Female
  • France / epidemiology
  • Humans
  • Malaria, Falciparum / complications*
  • Malaria, Falciparum / drug therapy
  • Malaria, Falciparum / mortality
  • Male
  • Quinine / therapeutic use
  • Respiration, Artificial
  • Respiratory Distress Syndrome / etiology*
  • Respiratory Distress Syndrome / mortality
  • Respiratory Distress Syndrome / therapy
  • Retrospective Studies
  • Shock, Septic / etiology
  • South America

Substances

  • Quinine